◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
BrightPath Biotherapeutics Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 14, 2025Q4 2024Nov 08, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
+Operating Income -542.6M -550.6M -- -- -- --
Operating Margin % 100.9% 99.8% -- -- -- --
+Ordinary Income -537.8M -551.6M -- -- -- --
Revenue Growth % 2.5% -- -- -- -- --
Line ItemQ4 2025Nov 14, 2025Q4 2024Nov 08, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
Current Assets 1.1B 1.2B -- -- -- --
Total Assets 1.1B 1.2B 1.4B 2.3B 3.3B 4.0B
Current Liabilities 131.7M 191.0M -- -- -- --
Total Liabilities 195.6M 251.3M 115.7M 147.3M 170.6M 185.1M
Total Equity 925.0M 979.0M 1.3B 2.1B 3.1B 3.8B
Equity Ratio -- -- 0.90 0.93 0.94 0.95
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...